Article
Poly(ADP-Ribose) Polymerase Inhibitor PJ34 Reduces Brain Damage after Stroke in the Neonatal Mouse Brain.
Current issues in molecular biology - 7 Jun 2021
Bonnin Philippe, Vitalis Tania, Schwendimann Leslie, Boutigny Alexandre, Mohamedi Nassim, Besson Valérie C, Charriaut-Marlangue Christiane
Abstract excerpt
The poly(ADP-ribose) polymerase inhibitor PJ34 has recently been reported to increase cerebral blood flow, via the endothelial NO synthase, in the naive mouse brain throughout life. We addressed here the benefits of PJ34 after neonatal ischemia on hemodynamics and components of the neurovascular unit including the blood-brain barrier (BBB), microglia, and astrocytes. Nine-day-old mice were subjected to permanent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
